Year:
 

ADHD

News

Page 1 of 3

Children with autism spectrum disorders frequently receive psychotropic drugs
Behavioral interventions typically are the first line of treatment to manage unwanted behaviors in children with autism spectrum disorders ( ASDs ). If behaviors do not improve, medications frequently are added to the mix. Research conducted by Autism Speaks' Autism Treatment Network ( ATN ) has...
Read Article
ADHD appears to be associated with depressed dopamine activity in the brain
Adults with attention-deficit / hyperactivity disorder ( ADHD ) show a blunted response to the Methylphenidate ( Ritalin ), which increases brain dopamine levels. This suggests that dopamine dysfunction may be involved with ADHD symptoms and may contribute to substance abuse that often occurs simul...
Read Article
ADHD Drugs linked to cardiovascular and psychiatric adverse events
The FDA ( Food and Drug Administration ) directed the manufacturers of all drug products approved for the treatment of Attention Deficit Hyperactivity Disorder ( ADHD ) to develop Patient Medication Guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms a...
Read Article
Long-term behavioral and neurological problems associated with prenatal exposure to cocaine
Cocaine use during pregnancy can cause subtle but disabling cognitive impairments -- attention deficits, learning disabilities and emotional problems. A study by researchers at the Vanderbilt Kennedy Center for Research on Human Development may help explain the long-term behavioral and neurologi...
Read Article
ADHD and narcolepsy: changes to Dexedrine boxed warnings and precautions
The FDA ( Food and Drug Administration ) has made changes to the boxed warning, warning, warning and precautions sections of the prescribing information for Dexedrine ( Dextroamphetamine sulfate ), approved for the treatment of ( ADHD ) Attention-Deficit Hyperactivity Disorder and narcolepsy. The wa...
Read Article
Preschoolers with ADHD improve with low doses of Ritalin
The PATS ( The Preschool ADHD Treatment Study ) trial designed to determine the safety and effectiveness of treating preschoolers who have attention deficit/hyperactivity disorder ( ADHD ) with Methylphenidate ( Ritalin ) has found that overall, low doses of this medication are effective and safe. H...
Read Article
Strattera, suspected association with tics
Health Canada has received 1 report of tics and 1 report of exacerbation of tics suspected of being associated with Strattera ( Atomoxetine ). In the first case, a 7-year-old girl was prescribed Atomoxetine 25 mg/d for attention deficit hyperactivity disorder ( ADHD ). Subsequently, the dose was ...
Read Article
Methylphenidate patch to treat attention deficit hyperactivity disorder in children, approved
FDA ( U.S. Food and Drug Administration ) approved Daytrana, the first transdermal patch, for treating Attention Deficit Hyperactivity Disorder ( ADHD ) in children six to 12 years of age. Daytrana is a once daily treatment containing the drug Methylphenidate, a central nervous system ( CNS ) sti...
Read Article
Eye movement test may help to identify children with fetal alcohol spectrum disorder
A simple test that measures eye movement may help to identify children with Fetal Alcohol Spectrum Disorder ( FASD ) and ultimately lead to improved treatment for the condition, say Queen's University researchers. At present there are no objective diagnostic tools that can be used to distinguish ...
Read Article
Antisocial behavior in children associated with gene variant and environmental risk factors
For children with attention deficit hyperactivity disorder ( ADHD ), possessing a variant of a gene involved in brain signaling may predict antisocial behavior and increase susceptibility to the effects of lower birth weight. The study is published in the Archives of General Psychiatry. Biolog...
Read Article
Pages:1, 2, 3 Next

Farmaci Home Novità Focus Farmacovigilanza Farmacia Pharma Progetto Farmaci Xapedia